Dr. Jamie L. Wagner
Rapid diagnostic technologies have ushered in a new era in infectious diseases, acting as a critical conduit between disease detection and treatment initiation. These technologies, which primarily center around molecular diagnostics, immunoassays and mass spectrometry, have enabled faster and more precise identification of pathogens, empowering providers to prescribe timelier, more effective treatments to improve patient outcomes.
While time to diagnosis